Results 131 to 140 of about 1,591,834 (257)

Technical Feasibility of IVIM for Prostate Cancer Imaging Using High‐Amplitude Whole‐Body Gradient System With Spiral Readout and Velocity‐Compensated Diffusion Encoding

open access: yesNMR in Biomedicine, Volume 39, Issue 10, October 2026.
The combination of velocity‐compensated diffusion encoding, spiral readout and strong gradients enabled high‐quality prostate IVIM imaging, offering a promising framework for the development of reliable IVIM‐based biomarkers for prostate cancer detection, characterisation and monitoring.
Malwina Molendowska   +6 more
wiley   +1 more source

Pathological extension of prostate cancer as defined by gleason score on biopsy

open access: yes, 2017
INTRODUCTION: Based on the importance of the Gleason score on the behavior of prostate adenocarcinoma, this study attempts to predict the extension of prostate adenocarcinoma pre-operatively, as defined by the Gleason score on biopsy, in individuals who ...
Crippa, Alexandre   +5 more
core  

Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of ‘‐mabs’?

open access: yesThe Journal of Pathology, Volume 270, Issue 2, Page 139-162, October 2026.
Abstract Prostate cancer (PCa) is the second most common type of neoplasm, currently treated with a variety of therapeutic agents. Although advances in treatment over the past decade have improved overall survival, patients with advanced PCa eventually progress from hormone‐sensitive PCa to metastatic castration‐resistant PCa.
Giuseppe Schepisi   +8 more
wiley   +1 more source

Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone‐Sensitive Prostate Cancer

open access: yesThe Prostate, Volume 86, Issue 14, Page 1461-1469, October 2026.
ABSTRACT Background Upfront treatment intensification with androgen deprivation therapy (ADT) plus an androgen receptor pathway inhibitor has become a standard approach for metastatic hormone‐sensitive prostate cancer (mHSPC). However, prognosis remains poor for some patients despite second‐generation androgen receptor antagonist‐based doublet therapy.
Saizo Fujimoto   +14 more
wiley   +1 more source

Gleason score

open access: yes, 2010
Jeremy Jones   +2 more
openaire   +1 more source

Predictive Value of [−2]proPSA‐Related Indices for Prostate Cancer Detection Years Before Prostate‐Specific Antigen Elevation: Insights From a Five‐Year Longitudinal Screening Cohort

open access: yesThe Prostate, Volume 86, Issue 14, Page 1470-1476, October 2026.
ABSTRACT Background [‐2]proPSA(p2PSA)‐related indices have demonstrated diagnostic value for detecting prostate cancer (PC) in males with modest increases in prostate‐specific antigen levels (PSA) of < 10 ng/mL. However, the “leak point” of p2PSA level in the blood circulation before developing screen‐detectable PC remains uncertain.
Yoshitaka Sekine   +11 more
wiley   +1 more source

Prostate Biopsy and Radical Prostatectomy Gleason Score Correlation in Heterogenous Tumors: Proposal for a Composite Gleason Score

open access: yes, 2015
When prostate biopsy cores are separately identified in multiple containers, current recommendations are to grade each specimen individually. For treatment algorithms, the highest Gleason score (HGS) is typically used as the overall score, even if a ...
Shah, Alpa B   +4 more
core   +1 more source

The effect of social identity on objective and perceived social support in groups

open access: yesBritish Journal of Social Psychology, Volume 65, Issue 4, October 2026.
Abstract The social identity approach posits that social identity fosters mutual social support within groups. However, prior research has relied almost exclusively on individual‐level self‐report measures, neglecting the mutuality of support and the group as a unit of analysis.
Julia Heimrich   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy